Palbociclib Impurity 33 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Palbociclib N-Acetic Acid is the oxidation product of Palbociclib. Palbociclib (named PD 0332991) is a novel highly selective cyclin-dependent kinase 4 and 6 (CDK 4/6) inhibitor, which has been approved by the Food and Drug Administration (FDA) for the treatment of hormone-receptor-pos. advanced breast cancer.

Palbociclib Impurity 33 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Palbociclib Impurity 33 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
China National Standard Pharmaceutical Corporation Limited	+8615391658522	overseasales@yongstandards.com	China	11922	58
Shenzhen ruikai de biotechnology co., ltd.	0755-61348847 17820674378	2682116078@qq.com	China	7843	58
Changzhou Bojia Biomedical Technology Co., Ltd.	2122619822	czbjpharma@126.com	China	18478	58
Shanghai Easy CDMO Co.,Ltd	021-61734564	August@easycdmo.com	China	10030	58
guoyungurui	18162595016; 18162595016	3287908757@qq.com	China	10335	58

---

• Glycine, N-[6-[(6-acetyl-8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-
• Palbociclib N-Acetic Acid
• (6-((6-Acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)glycine
• Barbituric Acid Impurity 15
• Palbociclib Impurity 144
• 2363160-84-1